Rs to adverse drug reactions reporting in community pharmacy settings in Dhaka, BangladeshMohammad Nurul Amin,1 Tahir Mehmood Khan,two Syed Masudur Rahman Dewan,1 Mohammad Safiqul Islam,1 Mizanur Rahman Moghal,1 Long Chiau Ming3,To cite: Amin MN, Khan TM, Dewan SMR, PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/21330118 et al. Crosssectional study exploring barriers to adverse drug reactions reporting in community pharmacy settings in Dhaka, Bangladesh. BMJ Open 2016;6:e010912. doi:10.1136bmjopen-2015010912 Prepublication history for this paper is out there on-line. To view these files please go to the journal on the web (http:dx.doi.org10.1136 bmjopen-2015-010912). Received 21 December 2015 Revised 29 March 2016 Accepted 29 AprilABSTRACT Objectives: To assess community pharmacists’pharmacy technicians’ information and perceptions about adverse drug reactions (ADRs) and barriers towards the reporting of such reactions in Dhaka, Bangladesh. Strategy: A cross-sectional study was planned to method prospective respondents for the study. A selfadministered questionnaire was delivered to community pharmacistspharmacy technicians (N=292) practising in Dhaka, Bangladesh. Results: The general response towards the survey was 69.five (n=203). The majority from the sample was comprised of pharmacy technicians (152, 74.9 ) who possessed a diploma in pharmacy, followed by pharmacists (37, 18.two ) and other people (12, five.9 ). Overall, 72 (35.5 ) with the respondents disclosed that they had seasoned an ADR at their pharmacy, but more than half (105, 51.7 ) were not familiar with the existence of an ADR reporting body in Bangladesh. Exploring the barriers towards the reporting of ADRs, it was revealed that the top 4 barriers to ADR reporting were `I don’t know how to report (Relative Value Index (RII)=0.998)’, `reporting forms aren’t obtainable (0.996)’, `I am not motivated to report (0.997)’ and `Unavailability of expert atmosphere to discuss about ADR (RII=0.939)’. Also to these, a majority (141, 69.46 ) were not confident concerning the classification of ADRs (RII=0.889) and were afraid of legal liabilities connected with reporting ADRs (RII=0.806). Furthermore, a lack of understanding about pharmacotherapy as well as the detection of ADRs was a different main aspect buy M2I-1 hindering their reporting (RII=0.731). Conclusions: The Directorate of Drug Administration in Bangladesh needs to take into consideration the results of this study to assist it improve and simplify ADR reporting in Bangladeshi community pharmacy settings.Strengths and limitations of this studyFindings in the current study will assist policymakers to understand the challenges to adverse drug reactions (ADRs) reporting in neighborhood pharmacy settings and therefore to intervene to make the ADR reporting procedure less complicated and much more accessible to pharmacists and pharmacy technicians practising in Bangladesh. The Directorate of Drug Administration in Bangladesh could make the ADR reporting procedure additional effective by generating the reporting forms easier to access. Furthermore, provided that unavailability of an expert environment to discuss about ADR was a major barrier identified for the reporting of ADRs, the Bangladeshi Pharmacy Association and registration councils can play a proactive role in organising frequent continuous education and coaching events exactly where pharmacists get the opportunity to discuss such experiences with other pharmacists. Among the list of possible limitations would be the modest quantity of pharmacists who participated within this study. Nonetheless, the whole sample was representative of Banglades.
Posted inUncategorized